Discovering the right compound that can treat an infection such as HIV is only the first piece of the drug development puzzle. The next challenge is to make the manufacturing process more efficient—and thereby cheaper. Killugudi Jayaraman meets with the 'process chemistry' experts honing these reactions to bring down the cost of antiretrovirals.
This is a preview of subscription content, access via your institution
Access options
Subscribe to Journal
Get full journal access for 1 year
$79.00
only $6.58 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.
References
Reddy, A.R. et al. Chem. Biol. Interface 3, 201–204 (2013).
Bellani, P., Frigerio, M & Castoldi, P. US Patent 6407252 (2002).
Ripin, D.H.B. et al. Org. Process Res. Dev. 14, 1194–1201 (2010).
Crawford, K.W. et al. Lancet Infect. Dis. 12, 550–560 (2012).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jayaraman, K. Finding the right chemistry. Nat Med 19, 1200–1203 (2013). https://doi.org/10.1038/nm1013-1200
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm1013-1200